Walid Chayouâ

577 total citations
17 papers, 375 citations indexed

About

Walid Chayouâ is a scholar working on Rheumatology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Walid Chayouâ has authored 17 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 12 papers in Hematology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Walid Chayouâ's work include Systemic Lupus Erythematosus Research (13 papers), Platelet Disorders and Treatments (11 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Walid Chayouâ is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Platelet Disorders and Treatments (11 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Walid Chayouâ collaborates with scholars based in Netherlands, Belgium and France. Walid Chayouâ's co-authors include Bas de Laat, Katrien Devreese, Jacek Musiał, Gary Moore, Hilde Kelchtermans, Denis Wahl, Jean‐Christophe Gris, Stéphane Zuily, Philip G. de Groot and Marisa Ninivaggi and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Walid Chayouâ

17 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walid Chayouâ Netherlands 12 307 218 85 67 51 17 375
Virginie Dufrost France 10 272 0.9× 210 1.0× 33 0.4× 48 0.7× 85 1.7× 21 402
SS Pierangeli United States 9 335 1.1× 227 1.0× 67 0.8× 63 0.9× 33 0.6× 11 414
Alessia Bracco Italy 11 257 0.8× 172 0.8× 103 1.2× 47 0.7× 58 1.1× 14 353
Oier Ateka–Barrutia United Kingdom 9 303 1.0× 165 0.8× 42 0.5× 56 0.8× 53 1.0× 13 358
Vinicius Domingues United States 8 267 0.9× 135 0.6× 29 0.3× 49 0.7× 59 1.2× 12 335
Maria Grazia Cattini Italy 11 190 0.6× 207 0.9× 37 0.4× 45 0.7× 80 1.6× 24 359
José A. Martínez-Flores Spain 12 284 0.9× 155 0.7× 77 0.9× 81 1.2× 19 0.4× 21 342
Linda K Barna United States 7 288 0.9× 266 1.2× 101 1.2× 52 0.8× 47 0.9× 9 417
Laya Blokzijl Netherlands 7 377 1.2× 222 1.0× 89 1.0× 47 0.7× 45 0.9× 8 440
Erika Chang Canada 8 270 0.9× 141 0.6× 43 0.5× 34 0.5× 49 1.0× 9 325

Countries citing papers authored by Walid Chayouâ

Since Specialization
Citations

This map shows the geographic impact of Walid Chayouâ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Chayouâ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Chayouâ more than expected).

Fields of papers citing papers by Walid Chayouâ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Chayouâ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Chayouâ. The network helps show where Walid Chayouâ may publish in the future.

Co-authorship network of co-authors of Walid Chayouâ

This figure shows the co-authorship network connecting the top 25 collaborators of Walid Chayouâ. A scholar is included among the top collaborators of Walid Chayouâ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid Chayouâ. Walid Chayouâ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Chayouâ, Walid, Marisa Ninivaggi, Mark Roest, et al.. (2023). OC 09.1 Epitope Specificity of Anti-Prothrombin Antibodies that Express Lupus Anticoagulant Activity. Research and Practice in Thrombosis and Haemostasis. 7. 100590–100590. 1 indexed citations
3.
Chayouâ, Walid, Marisa Ninivaggi, Mark Roest, et al.. (2023). Domain Specificity of Anti-Prothrombin Antibodies That Express Lupus Anticoagulant Activity. Blood. 142(Supplement 1). 5529–5529. 1 indexed citations
4.
5.
Chayouâ, Walid, Phillip L.R. Nicolson, Joost C.M. Meijers, et al.. (2021). Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome?. Journal of Thrombosis and Haemostasis. 19(7). 1776–1782. 18 indexed citations
6.
7.
Kremers, Romy, Denis Wahl, Stéphane Zuily, et al.. (2021). Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence. Thrombosis Research. 203. 142–151. 16 indexed citations
8.
Ninivaggi, Marisa, et al.. (2021). VWF, Platelets and the Antiphospholipid Syndrome. International Journal of Molecular Sciences. 22(8). 4200–4200. 24 indexed citations
9.
Mastenbroek, Tom G., Magdolna Nagy, Walid Chayouâ, et al.. (2020). Vascular protective effect of aspirin and rivaroxaban upon endothelial denudation of the mouse carotid artery. Scientific Reports. 10(1). 19360–19360. 4 indexed citations
10.
Chayouâ, Walid, Hilde Kelchtermans, Gary Moore, et al.. (2020). Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?. Thrombosis and Haemostasis. 120(11). 1557–1568. 22 indexed citations
11.
Chayouâ, Walid, Hilde Kelchtermans, Philip G. de Groot, et al.. (2019). Detection of anti‐domain I antibodies by chemiluminescence enables the identification of high‐risk antiphospholipid syndrome patients: A multicenter multiplatform study. Journal of Thrombosis and Haemostasis. 18(2). 463–478. 26 indexed citations
12.
Chayouâ, Walid, Philip G. de Groot, Stéphane Zuily, et al.. (2019). Brief Report on the 11th Meeting of the European Forum on Antiphospholipid Antibodies. Current Rheumatology Reports. 21(2). 6–6. 1 indexed citations
13.
Vorm, Lisa N. van der, Li Li, Dana Huskens, et al.. (2019). Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor. PLoS ONE. 14(2). e0211961–e0211961. 16 indexed citations
14.
Chayouâ, Walid, Hilde Kelchtermans, Jean‐Christophe Gris, et al.. (2019). The (non‐)sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 18(1). 169–179. 61 indexed citations
15.
Chayouâ, Walid, Hilde Kelchtermans, Gary Moore, et al.. (2019). Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms. Thrombosis and Haemostasis. 119(5). 797–806. 37 indexed citations
16.
Chayouâ, Walid, Hilde Kelchtermans, Gary Moore, et al.. (2018). Identification of high thrombotic risk triple‐positive antiphospholipid syndrome patients is dependent on anti‐cardiolipin and anti‐β2glycoprotein I antibody detection assays. Journal of Thrombosis and Haemostasis. 16(10). 2016–2023. 53 indexed citations
17.
Chayouâ, Walid, Hilde Kelchtermans, & Bas de Laat. (2017). The Significance of Antibodies against Domain I of Beta-2 Glycoprotein I in Antiphospholipid Syndrome. Seminars in Thrombosis and Hemostasis. 44(5). 458–465. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026